levetiracetam 5 mg/mL (Levetiracetam INJECTION, SOLUTION) 5 mg/mL

Levetiracetam 5 mg/mL injection is an anticonvulsant medication used to manage seizures. This intravenous solution is formulated for precise dosing and convenient administration.

Strength

5 mg/mL

Pack Size

10 BAG in 1 CARTON (25021-793-82) / 100 mL in 1 BAG

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Levetiracetam 5 mg/mL is primarily used to control seizures in adults and children with epilepsy. It works by affecting certain chemicals in the brain that may be involved in causing seizures. This medication is often prescribed as part of a comprehensive treatment plan for seizure management.

Side Effects

Common effects of levetiracetam 5 mg/mL may include drowsiness, dizziness, and fatigue. Some individuals may also experience headache or nausea. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

Levetiracetam 5 mg/mL should be handled with care, ensuring proper storage and administration. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always inform your healthcare provider about any allergies or other medications you are taking.

Avoid Interactions

Levetiracetam 5 mg/mL may interact with other medications, including other anticonvulsants, sedatives, and drugs that affect the central nervous system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol should be avoided as it may enhance the sedative effects of levetiracetam.

Frequently Asked Questions

Levetiracetam 5 mg/mL is used to manage seizures in adults and children with epilepsy.

Levetiracetam 5 mg/mL is administered intravenously, typically in a clinical setting.

Common side effects may include drowsiness, dizziness, fatigue, headache, and nausea.

Levetiracetam 5 mg/mL may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Precautions include following the prescribed dosage, informing your healthcare provider about allergies, and avoiding alcohol.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.